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ABSTRACT 
Mesenchymal stem cells (MSCs) have generated a promise as a potential source of cells for tissue 
engineering application due to their instrinsic ability to self-renew and differentiate into functional cell types. With 
their ability to differentiate into multiple cell phenotypes, mesenchymal stem cells offer the potential to regenerate 
entire tissue from a single cell source. Recent studies have demonstrated that MSCs were successfully used for bone 
repair, cartilage repair and soft tissue repair. This paper briefly outlines the biological characteristics of Mesenchymal 
stem cell and its application in tissue engineering field. 
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Tissue engineering is an 
interdisciplinary field that applies the principles 
of engineering and life science towards the 
development of functional substitutes that 
restore, maintain or improve tissue function1. 
The underlying principle involves the utilization 
of biocompatible scaffolds, cells and 
bioactive molecules to promote the 
differentiation and maturation of the cell type 
of interest. These components, when 
combined, form a tissue-engineered 
construct, which can function as the tissue 
replacement material2. One primary 
consideration in tissue engineered organ 
replacement is the choice of cells and the cell 
source. An ideal cell source for tissue 
engineering should have the capacity to 
proliferate and then differentiate in vitro, in a 
manner that can be reproducibly controlled. 
Human body houses several types of 
progenitor cells that are capable of dividing 
many times, while also giving rise to daughter 
cells with more restricted development 
potentials. Eventually these cells differentiate 
and have specific phenotypic characteristics 
that contribute to their highly specialized 
function. Examples of such stem cells include 
embryonic stem cells, hematopoietic stem 
cells and mesenchymal stem cells 3. Although 
the embryonic stem cells has pluripotent 
capability and can be propagated for more 
than two years with approximately 400 
population doubling cycles while maintaining  
a normal karotype, it has legal and moral 
controversies concerning their use for clinical 
application 4.  
Mesenchymal stem cells (MSCs) are 
present in a variety of tissues during human 
development, and in adults they are 
prevalent in bone marrow. They can be 
isolated and expanded with high efficiency, 
and induced to differentiate into multiple 
lineage under defined culture conditions. 
Along with their extensive capacity for self 
renewal, MSCs display a broad potential for 
generating diverse differentiated progenies 2. 
With their ability to differentiate into multiple 
cell phenotypes, MSCs offer the potential to 
regenerate entire tissue from a single cell 
source and have recently gained attention for 
tissue engineering applications 5,6,7. In various 
animal models, MSCs have been succesfully 
used for bone repair, cartilage repair and soft 
tissue repair 4,7. 
 
Characteristics of mesenchymal stem cell  
Mesenchymal stem cells (MSCs) are 
a heterogeneous population of 
stem/progenitor cells with multipotent 
capacity to differentiate into mesodermal 
and non-mesodermal cell lineages. MSCs 
reside primarily in the bone marrow, but also 
exist in other sites such as adipose tissue, 
periodontal ligament, deciduous teeth, hair 
follicles, scalp subcutaneous tissue, peripheral 
blood, liver, placenta, umbilical cord blood, 
and fetal tissues. It  can be plated and 
enriched using standard cell culture 
techniques 5,7,8. 
MSCs have a fibroblastic 
morphology in a monolayer culture and 
adhere to the tissue culture substrate (figure 
1). They start proliferating and form 
fibroblastic-like cell clusters (fibroblast colony 
forming units, CFU-F), whose number depends 
on MSCs clonogenic potential of the cell 
source. After splited and expanded, the cells 
become more homogenous and may 
proliferate without differentiating up to 35-40 
population doubling in culture. 
Immunodepletion methods involving 
CD34/CD45/CD11b may be used to generate 
purified MSCs preparation. Although not 
immortal, they have the ability to expand 
numerous times in culture while retaining their 
growth and multipotent potential 2,7. 
The minimal requirement for a 
population of cells to qualify as MSCs, as 
suggested by the International Society of the 
Isolated Cells in Culture, is to meet the three 
criteria, including (i) the plastic adherence of 
the isolated cells in culture, (ii) the expression 
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of CD105, CD73, and CD90 in greater than 
95% of the culture, and their lack of expression 
of markers including CD34, CD45, CD14 or 
CD11b, CD79a or CD19 and HLA-DR in greater 
than 95% of the culture, and (iii) the 
differentiation of the MSCs into bone, fat and 
cartilage 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Human mesenchymal stem cells from 
bone marrow2 
 
Differentiation of mesenchymal stem cells 
MSCs multi-lineage differentiation 
potential has been extensively studied in vitro 
since their firs discovery in 1960s . Under 
defined inductive conditions, MSCs are able 
to acquire characteristics of cells derived from 
embryonic mesoderm, such as osteoblasts, 
chondrocytes, adipocytes, tendon cells, as 
well as cells possessing ectodermal and 
neuronal properties (figure 2). The lineage 
commited cells can fabricate a spectrum of 
specialized mesenchymal tissue including 
bone, cartilage, muscle, marrow stroma, 
tendon, ligament, fat  and a variety of other 
connective tissues 3,9.    
However, the molecular mechanism 
that gover MSCs differentiation are 
incompletely understood. Baksh et al, 2004, 
have proposed a model for the regulation of 
adult stem cell differentiation, wich 
incorporates two continuous yet distinct 
compartements (figure 3). In first 
compartement, MSCs undergo transcriptional 
modification, generating percusor cells 
without apparent changes in phenotype and 
self-renewal capacity. Similar to MSCs residing 
in adult bone marrow, the majority of MSCs 
cultured in vitro remain quiescent and growth 
arrested in G0/G1, until stimulated, for 
example, by the supplementation of growth 
factors. Upon stimulation, multipotent, 
uncommitted MSCs undergo asymmetric 
division, giving rise to two daughter cells, one 
being the exact replica of the mother cell and 
maintaining multilineage potential, and the 
other daughter cell becoming a precursor 
cell, with a more restricted developmental 
program. In this model, the precursor cell 
continues to divide symmetrically, generating 
more tripotent and bipotent precursor cells. 
These tripotent and bipotent precursor cells 
are morphologically similar to the multipotent 
MSCs, but differ in their gene transcription 
repertoire, and therefore, still reside in the 
stem cell compartment. The progression of 
MSCs to precursor cells is considered the first 
step in stem cell commitment. The transition or 
exit from the ‘stem cell compartment’ to the 
‘commitment compartment’ occurs when 
precursor cells continue to divide 
symmetrically to generate unipotent 
progenitor cells, simultaneous with the 
acquisition of lineage specific properties, 
rendering them fully committed mature cells 
with distinguishable phenotypes. The 
commitment and differentiation of MSCs to 
specific mature cell types is a tightly and 
temporally controlled process, involving the 
activities of various transcription factors, 
growth factors, cytokines, and extracellular 
matrix molecules 9. 
 
Application of MSCs in tissue engineering 
MSCs present an progenitor cell 
source for applications of tissue engineering. It 
can be applied in the regeneration of bone, 
cartilage, soft tissue such as tendon, adipose 
and muscle. Combined with biocompatible 
scaffold and stimulated by specific growth 
factors, it construct biologic substitutes that will 
restore, maintain, and improve tissue functions 
following damage either by disease or 
traumatic processes. 
Based on in vitro observation that 
MSCs can differentiate into osteocytes and 
chondrocytes, many attemps have been 
made to use expanded MSCs for in vivo tissue 
repair. For orthopedic applications, especially 
for bone formation, the use of natural or 
synthetic biomaterials have been used as 
carriers for MSCs delivery. As reviewed by 
Krampera et al7, porous ceramic scaffolds 
loaded with in vitro expanded autologous 
bone-marrow derived MSCs were successfully 
implanted in 3 patients with large bone 
defect. An extended mandible discontinuity 
was successfully repaired through a 
heterotopic bone induction with biomaterials, 
patient’s bone marrow and growth factors.  
The use of synthetic polymers 
particularly PLA and PLGA, is also promising 
and applicable for the clinical reconstruction 
of joint cartilage defect. The induction of 
chondrogenic differentiation of bone marrow 
MSCs by tridimensional matrices and scaffolds 
has been studies in vivo in the presence of 
cytokines and recombinant human bone 
morphogenetic protein-2 (rhBMP-2). This 
approach that combines regenerating cells, 
bioactive matrices and osteoinductive growth 
factors seems to be mostly effective for the 
treatment of joint cartilage defect 7. 
Induction of MSC differentiation into 
connective tissues other than bone and 
cartilage, such as tendons and ligaments, has 
been investigated for a potential clinical 
application.
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Figure 2. The stepwise cellular transitions from the putative MSCs to highly differentiated phenotypes 
are dipected schematically3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic model depicting adult stem cell differentiation. Uncommitted MSCs undergo two 
stages, occurring in the stem cell compartment and the committed cell compartment, prior to 
acquiring specific phenotypes. In the stem cell compartment, multipotent MSCs give rise to a less 
potent cell population via asymmetric cell division (A), which then generate more precursor cells with 
less self-renewal capacity and more restricted differentiation potential via symmetric division (S). In the 
committed cell compartment, these tri-or bi-potent precursor cells continue to divide symmetrically 
and generate bi- or unipotent progenitor cells with pre-determined cell fate, which eventually give rise 
to fully differentiated cells. Recent studies also suggest that the fully committed cells are able to 
dedifferentiate into more potent cells, and acquire a different phenotype under inductive cues (open 
arrows) 9. 
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Induction of MSC differentiation into 
connective tissues other than bone and 
cartilage, such as tendons and ligaments, has 
been investigated for a potential clinical 
application. MSCs-collagen composites were 
implanted into long gap defects in the rabbit 
Achilles tendon: biochemical and histological 
analysis revealed an improvement of 
biomechanical properties, tissue architecture 
and functionality of the tendon after injury.At 
12weeks post-surgery, the modulus and 
maximum stress for the repair tissue were 34% 
and 37%, respectively, of normal values. A 
further enhancement of tendon and ligament 
tissue regeneration derives from the use of 
exogenous growth/differentiation factors 
(GDF), for example, GDF-5, GDF-6 and GDF-7, 
which have been implicated in tendon 
formation 4,7.  
 
CONCLUSION 
Mesenchymal stem cells present an 
exciting progenitor cell source for applications 
of tissue engineering.  Although much have 
been learnt about MSCs, a multidisiplinary 
approach still needed to discover more about 
the of using MSCs in tissue engineering. 
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